BIO|CONCEPT.BIOMONITOR-HF Collect Clinical Data From Heart Failure Patients Using BIOMONITOR Devices With a Study Specific Research Software

Inclusion Criteria

• •Patient has diagnosed heart failure for ≥90 days and current symptoms compatible with NYHA class II-III (according to most recent assessment)
• •At least ONE of the following:
• •At least one documented admission with a primary diagnosis of worsening heart failure within last 12 months prior to enrollment;
• •OR Unscheduled outpatient visit with increase of oral loop diuretics (more than 2-fold) or IV diuretic or ultrafiltration therapy for acute WHF within last 6 months prior to enrollment;
• •OR elevated NT-proBNP/BNP values within last 3 months prior to enrollment i.e.:
• •If LVEF \>50% --\> Patients in SR: \>450 / \>150 pg/ml; Patients with AF present: \>900 / \>300 pg/ml
• •If LVEF \<50% --\> Patients in SR: \>900 / \>300 pg/ml; Patients with AF present: \>1800 / \>450 pg/ml
• •Ability to understand the nature of the study
• •Willingness to provide written informed consent
• •Ability and willingness to perform follow-up visits at the study site and via phone
• •Ability and willingness to use the CardioMessenger and acceptance of the BIOTRONIK Home Monitoring concept